--- title: 108Labs announces the M2 Milk Platform and reorganization across health & food product fields description: 108Labs announces the M2™ smart bioreactor milk production platform. image: https://news.lifesciencenewswire.com/hubfs/Cell-cultured%20milk%20is%20Pure%E2%84%A2%20Milk.jpg --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (34)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (20)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (15)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (244)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (9)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (36)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (108)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (283)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (35)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Drug Discovery & Development (147)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (55)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (132)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (6)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (25)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (86)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (114)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (4)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (5)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates - ##### SHARE - - - # [108Labs announces the M2 Milk Platform and reorganization across health & food product fields](https://news.lifesciencenewswire.com/newsroom/108labs-announces-the-m2-milk-platform-and-reorganization-across-health-food-product-fields) March 21, 2022 *Building the future of food in the birthplace of cell-cultured milk* [![Cell-cultured milk is Pure™ Milk](https://news.lifesciencenewswire.com/hs-fs/hubfs/Cell-cultured%20milk%20is%20Pure%E2%84%A2%20Milk.jpg?width=430&name=Cell-cultured%20milk%20is%20Pure%E2%84%A2%20Milk.jpg)](https://drive.google.com/file/d/1MixXSTGwQNiVmWiGBwOl-PobPNbPV13v/view?usp=sharing)Conjuring the Magic of Milk, 108Labs announces the M2™ smart bioreactor milk production platform. M2 is a turnkey wetware, software, and hardware milk-making stack driven by artificial intelligence to reduce the cost and accelerate the scaling of cell-cultured milk production worldwide. Human milk is the most important and least accessible food on earth. Cell-cultured bovine milk may retire cows and slow global warming some day. The mission of 108Labs’ newly organized entities is to accelerate the future of human milk and replacement dairy across many health and food product fields with the M2 platform. *108Labs entities:* Pure Mammary Factors, Inc. was founded in December 2021 and is democratizing cell-cultured milks by making product research and commercialization more affordable and accessible. A Pure™ dairy product is any cell-cultured milk product created with Pure Mammary Factors. Unlike raw milk, Pure mammary cell medium and growth factors produce Pure milks that are safe for human consumption right out of the cell without needing pasteurization. M2Health, Inc. was founded in May 2020 and is developing Pure therapeutic human milk for prescription drugs and humanized infant formula products. M2Foods, Inc. was founded in September 2021 and is developing Pure foods including bovine artisanal cheeses and other replacement dairy food products. 108Labs and 108Labs entities are licensing M2 and collaborating with dairy, food and pharmaceutical partners to accelerate Pure food and health products to market worldwide. “What 108Labs has accomplished as a self-funded, family-run incubator over the last decade is astonishing, but the future is even more amazing and I couldn’t be more excited to work with Shayne and 108Labs on the future of food.” - Scott Matthews, COO, M2Foods About M2Health, Inc M2Health operates at the 108Labs Kelly Ann Machovec Human Milk Institute in Hillsborough, NC, where 108Labs and M2Health are developing multiple Pure human milk derived health products like humanized infant formula and prescription drugs through collaborations with dairy and pharmaceutical companies around the world. About M2Foods, Inc M2Foods operates out of the Piedmont Food Facility under FDA inspection in Hillsborough, NC, and leverages M2 and Pure Mammary Factors to develop the world’s first dairy replacement food products both internally and in collaboration with food and dairy companies around the world, beginning with small batch Pure Piedmont Artisanal Cheese - hopefully coming soon to restaurants near Hillsborough, North Carolina, the birthplace of cell-cultured milks. About Pure Mammary Factors, Inc Pure Mammary Factors is operating adjacent to the 108Labs Human Milk Institute and was born from a vision to crash the cost of cell-cultured milks with precision fermented growth factors and optimized mammary medium formulations. Pure Mammary Factors’ mission is to reduce the barrier of entry for Pure™ dairy product research and product commercialization by solving the central problems of affordability and accessibility in the emerging field of cell-cultured milks. About 108Labs, LLC 108Labs has incubated the fields of cell-cultured milk and immunoglobulins since 2013, and is operating multiple research labs and subsidiaries in North Carolina and California in order to engineer M2 and collaborate and license its emerging fields of cell-cultured milks and antibodies with partners around the world. [108Labs](http://108labs.net/) was founded as a software and biotechnology company in 2013 with a simple mission to invent novel cellular agriculture projects to disrupt animal agriculture. 108Labs successfully conceived, invented, patented and incubated the world’s first cell-cultured human milk and human milk antibodies by early 2020. 108Labs’ M2 milk platform will fulfill 108Labs’ original dream to feed and heal the world with Cellufacturing® innovations. 108Labs, LLC, All Rights Reserved ©2022 Categories: [Food & Beverage](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) ##### Browse more news ## Recent releases #### [Enhanced Compliance Inc. (ECI) Appoints Taranjit S. Samra as Head of Medical Device Software Enginee...](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) July 6, 2026 Strengthens ECI’s AI & Digital Transformation capabilities to help clients develop the next generation of software-enabled medical technologies En... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/enhanced-compliance-inc.-eci-appoints-taranjit-s.-samra-as-head-of-medical-device-software-engineering-cybersecurity-and-ai) #### [Alithea Genomics Launches Early Access Program for MERCURIUS™ 1536 DRUG-seq, Bringing Transcriptomic...](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) June 16, 2026 New ultra-high-throughput kit enables discovery teams to generate transcriptome-wide compound-response data directly from 1536-well plates Alithea Gen... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/alithea-genomics-launches-early-access-program-for-mercurius-1536-drug-seq-bringing-transcriptomics-to-compound-screening-scale) #### [Arscience Biotherapeutics Appoints Gustavo Mahler as Chief Executive Officer](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) June 16, 2026 Seasoned Biopharmaceutical Leader and Board Director Steps Up to Lead the Company’s Next Phase of Growth in Customized Interleukin Therapies ARScience... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arscience-biotherapeutics-appoints-gustavo-mahler-as-chief-executive-officer) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)